Stockreport

Candel Therapeutics to Present at the SITC 2025 Annual Meeting

Candel Therapeutics, Inc.  (CADL) 
PDF NEEDHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused [Read more]